Search

everythinglearnresearchcommunity

for

Search:↓

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Ritlecitinib is safe and may effectively treat alopecia areata.

GnRH treatment can reduce breast cancer cell invasion.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Signals from skin cells controlled by Rac proteins help turn certain precursor cells into white fat cells.

CD133+ cells are crucial for hair growth.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Clim proteins are essential for maintaining healthy corneas and hair follicles.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

The MtAnn3 gene affects root hair growth and is influenced by cytokinin.

Ginsenosides Rb₁ and Rd may help prevent hair loss by promoting hair cell growth.

Trps1 is essential for proper hair follicle development.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

NDRG1 protein helps infantile hemangioma, a common infant tumor, to grow, and its mismanagement by FOXO1 protein plays a big role in causing the tumor.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Phosphorylation of certain parts of the PIN3 protein is crucial for its role in plant root growth and response to gravity.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

Mouse Scube3 affects teeth, tongue, vibrissae, and eye development, but not facial structure or limb growth.